In 2023, Parkinson's disease mortality among males in Canada stood at 2.23 thousand. Forecasts indicate a steady rise in mortality, reaching 2.5 thousand by 2028. The year-on-year growth rates are modest, increasing each year by approximately 2% to 3%. Over the past and projected five-year period, the compound annual growth rate (CAGR) suggests an average annual increase of around 2.3%.

Future trends to watch for:

Advancements in medical treatments potentially altering mortality rates.
Demographic shifts, such as aging population, that may impact disease prevalence.
Public health interventions aimed at disease prevention and early diagnosis.